Mar 2, 2026 by Dan CaplingerThis ETF Has Delivered Massive Returns for 33 Years -- And It's Just Hitting Its StrideFor some investors, you can't improve on the original.
Mar 2, 2026 by David Jagielski, CPAUnitedHealth's Stock Might Not Rally Until This Number ImprovesThe company's rising costs are a big reason investors have been dumping the stock of late.
Mar 2, 2026 by David Jagielski, CPAUp Over 400% in 5 Years, Is It Too Late to Invest in Eli Lilly Stock?Eli Lilly has been a growth beast in recent years, but its valuation has gotten fairly high along the way.
Mar 2, 2026 by Selena Maranjian1 Reason I'd Happily Buy Pfizer (PFE) Stock and Never SellThe reason is so compelling that I actually did buy the stock -- and I have no plans to sell.
Mar 2, 2026 by Dan CaplingerThis ETF Has Delivered Massive Returns for 33 Years -- And It's Just Hitting Its StrideFor some investors, you can't improve on the original.
Mar 2, 2026 by Josh Kohn-LindquistWhy Turning Point Brands Stock Is Plummeting TodayTurning Point's pivot to white nicotine pouches is going well, but is temporarily weighing on the company's profitability.
Mar 2, 2026 by Jonathan PoncianoMercadoLibre Hits $14.5 Billion Sales as New $829 Million Position SurfacesMercadoLibre operates a leading e-commerce and fintech platform serving consumers and businesses across Latin America.
Mar 2, 2026 by David Jagielski, CPAUnitedHealth's Stock Might Not Rally Until This Number ImprovesThe company's rising costs are a big reason investors have been dumping the stock of late.
Mar 2, 2026 by David Jagielski, CPAUp Over 400% in 5 Years, Is It Too Late to Invest in Eli Lilly Stock?Eli Lilly has been a growth beast in recent years, but its valuation has gotten fairly high along the way.
Mar 2, 2026 by David Jagielski, CPAIs CRISPR Therapeutics Stock Too Risky to Buy Right Now?CRISPR isn't profitable, but it does have an approved gene therapy treatment with loads of potential.
Mar 2, 2026 by Lawrence NgaWhere Could Duolingo Be in 3 Years?Will it be a durable AI-powered subscription platform, or a mature consumer app facing new competitive pressures?
Mar 2, 2026 by David Jagielski, CPAWhy AbbVie Stock May Be the Ultimate Option for Dividend InvestorsAbbVie pays a high dividend, has grown its payout regularly, and has a strong underlying business.
Mar 2, 2026 by David Jagielski, CPAWhy I'm Not Worried About Novo Nordisk StockThe stock is down big of late, but the business is by no means doomed.
Mar 2, 2026 by Neil Rozenbaum2 Beaten-Down Growth Stocks: 1 to Buy and 1 to AvoidDuolingo, Shift4, CoreWeave, or Netflix? 2 of these are down by more than 45%. Here is the one I'm buying hand over fist.
Mar 2, 2026 by Jonathan PoncianoTerex Stock Has Surged Nearly 70% This Past Year, so Why Did One Fund Exit a $27 Million Stake?Terex manufactures aerial work platforms and material processing equipment for global construction, infrastructure, and industrial markets.
Mar 2, 2026 by Motley Fool StaffRule Breaker Investing Mailbag: Listeners Air Their GrievancesWhat wording drives you bonkers?
Mar 2, 2026 by Leo SunHow Buying Nio Stock Today Could 10x Your Net WorthThis Chinese EV maker still has a bright future.
Mar 2, 2026 by Jason Hall and Tyler CroweIs Nvidia Stock a Buy Now?The GPU giant is in solid shape, but these upstarts with big CPU businesses may be better buys right now.
Mar 2, 2026 by Neil PatelUp 1,000%, Should You Buy Apple Right Now?It's time to take a fresh look at one of the most valuable companies ever.
Mar 2, 2026 by Rich SmithWhy Did Alphabet Stock Drop Today?Apple's giving even more money to Google now -- but is it enough to make Alphabet stock a buy?
Mar 2, 2026 by Jonathan PoncianoWix Stock Has Tanked 70% This Past Year, and One Investor Sold $6 Million in Shares Last QuarterWix.com offers cloud-based website creation and business tools worldwide, generating recurring revenue through its subscription model.
Mar 2, 2026 by Neil RozenbaumThe Doomsday Scenario That Caused Wall Street to Panic Makes Little SenseCitrini Research put out a bearish scenario, and the market just ran with it without understanding the full picture.
Mar 2, 2026 by Jonathan PoncianoChart Industries Just Delivered $1 Billion in Adjusted EBITDA, so Why Did One Investor Sell Off $54 Million in Stock?Chart Industries delivers engineered equipment and solutions for energy, industrial gas, and clean tech markets worldwide.
